Neue Suche | Kongressdetail
mail
Druckansicht
 
 

4th Treg Directed Therapies Summit

Evvnt Promotion / evvnt
Archiv
-
17.05.2022 - 19.05.2022  Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, 02128 Boston, USA
Time: 09:00 - 17:30
 
Kongressthemen
As Biopharma turn their focus to autoimmune drug development, there has been an explosion of interest and investment into Treg directed therapies. Promising proof-of-concept data and early clinical read outs have fueled further hype, and the industry now looks to demonstrate efficacy.

The 4th Treg Directed Therapies Summit returns to Boston this May, bigger and better than ever before, boasting 2 tracks of unparalleled content to cater to cell-based, and non-cell-based experts alike.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Richard Ransohof, Co-Founder and CMO Abata and Venture Partner, Third Rock Ventures, Thomas Wickham, CSO, GentiBio, Jonathan Zalevsky, Chief Research and Development Officer, Nektar Therapeutics and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/991160-2?pid=4832
Herr Treg Directed Therapies Summit Team
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 2599.0 - USD 5846.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

AMREF - African Medical and Research FoundationHilfswerk AustriaAlumni Club Medizinische Universität WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Center of ExcellenceÖsterreichische Gesellschaft für Public HealthSwiss Tropical and Public Health InstituteEuropean Health Forum Gastein